Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. R. Keller
Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Recent Developments in Photoelectron Dynamics Using Synchrotron Radiation
IEEE Transactions on Nuclear Science
Electronic Engineering
Nuclear
Nuclear Energy
High Energy Physics
Engineering
Electrical
Related publications
Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Pertuzumab Increases Epidermal Growth Factor Receptor Down-Regulation by Counteracting Epidermal Growth Factor Receptor-ErbB2 Heterodimerization
Molecular Cancer Therapeutics
Cancer Research
Oncology
Is There a Role for Dacomitinib, a Second-Generation Irreversible Inhibitor of the Epidermal-Growth Factor Receptor Tyrosine Kinase, in Advanced Non-Small Cell Lung Cancer?
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model
British Journal of Cancer
Cancer Research
Oncology
Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas
Molecular Cancer Therapeutics
Cancer Research
Oncology
Lung Cancer Cells Survive Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Exposure Through Upregulation of Cholesterol Synthesis
FASEB BioAdvances
Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study
Biomedical Journal
Medicine
Local Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor May Provide a New Therapeutic Potential for the Treatment of Intractable Upper Airway Inflammation
Journal of Japan Society of Immunology & Allergology in Otolaryngology
Genetic Alterations in Epidermal Growth Factor Receptor‑tyrosine Kinase Inhibitor‑na�ve Non‑small Cell Lung Carcinoma
Oncology Letters
Cancer Research
Oncology
